But his report also revealed the failure of regulation that is amazing. It identified the weaknesses in UK healthcare decisions. And it shows why open the NHS to private providers such as venture and ill-considered harmful.
A reasonable conclusion can be that the MHRA failed to do the job society expects — to protect her from harm. French authorities last December suggest women, based on their assessment of the evidence, to consider deletion of PIP implants. The MHRA replied on the same day to disagree. The MHRA argues that it “does not believe that the associated risks of breast implant removal surgery can be justified without further proof.” This assessment is in a hurry, arrogant, and completely at odds with concerns regarding PIP implants. Keogh did their best to offer a collegial support to the MHRA. He wrote that he agreed that there was “no particular security concerns” and that there was “no clear evidence on the patients with implants PIP at the risk of losses that are greater than other implants”.